[144] Axogen, Inc. SEC Filing

Rhea-AI Filing Summary

Axogen, Inc. insider filed a Form 144 notifying a proposed sale of 7,620 shares of common stock through Morgan Stanley Smith Barney LLC with an aggregate market value of $136,169.40. The filing lists the number of shares outstanding as 46,012,574 and an approximate sale date of 10/02/2025 on NASDAQ. The securities were acquired as Restricted Stock Units on 09/01/2024 from the issuer and the filing reports "Nothing to Report" for sales in the prior three months. The Form 144 includes the standard signature representation that the seller is not aware of undisclosed material adverse information.

Insights

Corporate Governance Analyst

TL;DR: Insider submitted a routine Form 144 to sell 7,620 shares via Morgan Stanley Smith Barney.

The filing documents a proposed sale of 7,620 common shares with an aggregate market value of $136,169.40 and lists 46,012,574 shares outstanding. The shares were acquired as Restricted Stock Units on 09/01/2024.

The notice states the planned sale date as 10/02/2025 on NASDAQ and reports no sales in the prior three months. This is a procedural disclosure required under Rule 144; the filing contains the signer’s representation about not possessing undisclosed material adverse information.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7620	136169.40	46012574	10/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2024	Restricted Stock Units	Issuer			7620	09/01/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the AXGN Form 144 disclose?

The filing discloses a proposed sale of 7,620 common shares with aggregate market value $136,169.40, through Morgan Stanley Smith Barney LLC.

When is the planned sale date on the AXGN Form 144?

The approximate date of sale listed is 10/02/2025.

How and when were the shares being sold acquired according to the filing?

The shares were acquired as Restricted Stock Units on 09/01/2024 from the issuer.

Does the filing report any sales in the prior three months for the selling person?

The filing states "Nothing to Report" for securities sold during the past three months.

Which broker is handling the proposed sale in the Form 144?

The broker named is Morgan Stanley Smith Barney LLC, New York, NY.